| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 1.61e-11 | 28 | 16 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 5.29e-11 | 35 | 16 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.77e-10 | 48 | 16 | 5 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.09e-10 | 49 | 16 | 5 | GO:0019840 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.68e-08 | 107 | 16 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.01e-07 | 153 | 16 | 5 | GO:0008194 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 4.08e-07 | 398 | 16 | 6 | GO:0046982 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 4.99e-07 | 211 | 16 | 5 | GO:0016758 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 9.24e-07 | 239 | 16 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | organic acid binding | 1.25e-06 | 254 | 16 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 2.31e-06 | 288 | 16 | 5 | GO:0016757 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 2.56e-05 | 815 | 16 | 6 | GO:0042803 | |
| GeneOntologyMolecularFunction | lipid binding | 7.54e-05 | 988 | 16 | 6 | GO:0008289 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 2.26e-04 | 1205 | 16 | 6 | GO:0046983 | |
| GeneOntologyMolecularFunction | steroid binding | 4.97e-03 | 133 | 16 | 2 | GO:0005496 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 5.49e-03 | 140 | 16 | 2 | GO:0001221 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 2.84e-12 | 21 | 16 | 5 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 9.15e-12 | 26 | 16 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 9.15e-12 | 26 | 16 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | bilirubin conjugation | 5.64e-07 | 2 | 16 | 2 | GO:0006789 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 5.63e-06 | 5 | 16 | 2 | GO:0052696 | |
| GeneOntologyBiologicalProcess | vitamin D3 metabolic process | 2.02e-05 | 9 | 16 | 2 | GO:0070640 | |
| GeneOntologyBiologicalProcess | cellular response to corticosteroid stimulus | 3.15e-05 | 81 | 16 | 3 | GO:0071384 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 3.71e-05 | 12 | 16 | 2 | GO:0052697 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound catabolic process | 4.38e-05 | 13 | 16 | 2 | GO:0006787 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 4.38e-05 | 13 | 16 | 2 | GO:0009812 | |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 5.11e-05 | 14 | 16 | 2 | GO:0033015 | |
| GeneOntologyBiologicalProcess | vitamin D metabolic process | 1.41e-04 | 23 | 16 | 2 | GO:0042359 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.64e-04 | 141 | 16 | 3 | GO:0006805 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | 1.74e-04 | 731 | 16 | 5 | GO:0032787 | |
| GeneOntologyBiologicalProcess | response to corticosteroid | 3.65e-04 | 185 | 16 | 3 | GO:0031960 | |
| GeneOntologyBiologicalProcess | benzene-containing compound metabolic process | 3.70e-04 | 37 | 16 | 2 | GO:0042537 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 4.33e-04 | 40 | 16 | 2 | GO:0042573 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 5.92e-04 | 525 | 16 | 4 | GO:0009410 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 6.21e-04 | 222 | 16 | 3 | GO:0071466 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin metabolic process | 7.04e-04 | 51 | 16 | 2 | GO:0006775 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 7.31e-04 | 52 | 16 | 2 | GO:0008210 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 7.70e-04 | 239 | 16 | 3 | GO:0071383 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | 8.65e-04 | 1035 | 16 | 5 | GO:0019752 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | 9.56e-04 | 1058 | 16 | 5 | GO:0043436 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 9.80e-04 | 1064 | 16 | 5 | GO:0006082 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound metabolic process | 1.07e-03 | 63 | 16 | 2 | GO:0006778 | |
| GeneOntologyBiologicalProcess | cellular response to glucocorticoid stimulus | 1.25e-03 | 68 | 16 | 2 | GO:0071385 | |
| GeneOntologyBiologicalProcess | tetrapyrrole metabolic process | 1.44e-03 | 73 | 16 | 2 | GO:0033013 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 2.12e-03 | 89 | 16 | 2 | GO:0001523 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 2.37e-03 | 94 | 16 | 2 | GO:0042440 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 2.37e-03 | 94 | 16 | 2 | GO:0016101 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 2.82e-03 | 376 | 16 | 3 | GO:0008202 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 2.93e-03 | 381 | 16 | 3 | GO:0048545 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 2.94e-03 | 105 | 16 | 2 | GO:0006721 | |
| GeneOntologyBiologicalProcess | renal tubule development | 3.57e-03 | 116 | 16 | 2 | GO:0061326 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 4.46e-03 | 130 | 16 | 2 | GO:0097306 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 4.67e-03 | 133 | 16 | 2 | GO:0006766 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 2.59e-04 | 1293 | 16 | 6 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 2.65e-04 | 1299 | 16 | 6 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 2.98e-04 | 1327 | 16 | 6 | GO:0042175 | |
| Domain | UDPGT | 3.21e-12 | 21 | 15 | 5 | PF00201 | |
| Domain | UDP_glucos_trans | 3.21e-12 | 21 | 15 | 5 | IPR002213 | |
| Domain | UDPGT | 3.21e-12 | 21 | 15 | 5 | PS00375 | |
| Domain | - | 1.57e-02 | 679 | 15 | 3 | 3.30.160.60 | |
| Domain | zf-C2H2 | 1.66e-02 | 693 | 15 | 3 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.66e-02 | 694 | 15 | 3 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 2.23e-02 | 775 | 15 | 3 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 2.24e-02 | 777 | 15 | 3 | PS00028 | |
| Domain | Znf_C2H2-like | 2.39e-02 | 796 | 15 | 3 | IPR015880 | |
| Domain | Znf_C2H2 | 2.46e-02 | 805 | 15 | 3 | IPR007087 | |
| Domain | ZnF_C2H2 | 2.49e-02 | 808 | 15 | 3 | SM00355 | |
| Domain | zf-C2H2_6 | 2.56e-02 | 314 | 15 | 2 | PF13912 | |
| Pathway | REACTOME_GLUCURONIDATION | 9.00e-12 | 25 | 12 | 5 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 9.00e-12 | 25 | 12 | 5 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.11e-11 | 26 | 12 | 5 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.66e-11 | 28 | 12 | 5 | M19580 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.26e-10 | 41 | 12 | 5 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.83e-10 | 44 | 12 | 5 | M45014 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 3.94e-10 | 51 | 12 | 5 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 4.35e-10 | 52 | 12 | 5 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 5.82e-10 | 55 | 12 | 5 | M14933 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.27e-09 | 64 | 12 | 5 | M9488 | |
| Pathway | REACTOME_HEME_DEGRADATION | 1.45e-09 | 20 | 12 | 4 | MM14721 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.01e-09 | 70 | 12 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 2.32e-09 | 72 | 12 | 5 | M9257 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.17e-09 | 24 | 12 | 4 | MM14599 | |
| Pathway | WP_GLUCURONIDATION | 3.77e-09 | 25 | 12 | 4 | MM15820 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 1.07e-08 | 32 | 12 | 4 | MM14719 | |
| Pathway | REACTOME_DRUG_ADME | 1.91e-08 | 109 | 12 | 5 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.91e-08 | 109 | 12 | 5 | M18788 | |
| Pathway | REACTOME_ASPIRIN_ADME | 4.40e-08 | 45 | 12 | 4 | MM15694 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 2.13e-07 | 15 | 12 | 3 | MM15697 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 2.57e-07 | 183 | 12 | 5 | M39588 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 3.82e-07 | 18 | 12 | 3 | M39424 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 6.41e-07 | 220 | 12 | 5 | M10320 | |
| Pathway | WP_ESTROGEN_METABOLISM | 7.19e-07 | 22 | 12 | 3 | MM15888 | |
| Pathway | REACTOME_PREDNISONE_ADME | 8.27e-07 | 23 | 12 | 3 | MM16639 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.48e-06 | 107 | 12 | 4 | MM14595 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 2.09e-06 | 31 | 12 | 3 | M39476 | |
| Pathway | REACTOME_DRUG_ADME | 2.27e-06 | 119 | 12 | 4 | MM15692 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 2.31e-06 | 32 | 12 | 3 | M39567 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 6.17e-06 | 153 | 12 | 4 | MM15844 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 6.55e-06 | 45 | 12 | 3 | M39615 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 2.54e-05 | 219 | 12 | 4 | MM14838 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 6.01e-05 | 14 | 12 | 2 | M39328 | |
| Pathway | REACTOME_HEME_DEGRADATION | 6.93e-05 | 15 | 12 | 2 | M27060 | |
| Pathway | WP_NRF2_PATHWAY | 2.02e-04 | 141 | 12 | 3 | M39454 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 2.19e-04 | 145 | 12 | 3 | M45512 | |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 2.30e-04 | 27 | 12 | 2 | M1088 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.66e-04 | 29 | 12 | 2 | M45015 | |
| Pathway | REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES | 3.67e-04 | 34 | 12 | 2 | M27461 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 2.07e-03 | 314 | 12 | 3 | M39428 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.84e-02 | 250 | 12 | 2 | M27554 | |
| Pubmed | 1.30e-15 | 9 | 16 | 5 | 22511988 | ||
| Pubmed | 1.30e-15 | 9 | 16 | 5 | 1339448 | ||
| Pubmed | 2.59e-15 | 10 | 16 | 5 | 23642732 | ||
| Pubmed | 2.59e-15 | 10 | 16 | 5 | 11465080 | ||
| Pubmed | 2.59e-15 | 10 | 16 | 5 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.59e-15 | 10 | 16 | 5 | 22558097 | |
| Pubmed | 8.15e-15 | 12 | 16 | 5 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 8.15e-15 | 12 | 16 | 5 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.32e-14 | 13 | 16 | 5 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.32e-14 | 13 | 16 | 5 | 25246029 | |
| Pubmed | 2.06e-14 | 14 | 16 | 5 | 21646302 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 2.06e-14 | 14 | 16 | 5 | 14672974 | |
| Pubmed | 2.06e-14 | 14 | 16 | 5 | 9295054 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 2.06e-14 | 14 | 16 | 5 | 10836148 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 4.49e-14 | 16 | 16 | 5 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 6.36e-14 | 17 | 16 | 5 | 20639394 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.19e-13 | 19 | 16 | 5 | 23281178 | |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 4.36e-13 | 24 | 16 | 5 | 24625756 | |
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 4.48e-13 | 6 | 16 | 4 | 19204906 | |
| Pubmed | 2.09e-12 | 8 | 16 | 4 | 22579593 | ||
| Pubmed | 2.09e-12 | 8 | 16 | 4 | 17179145 | ||
| Pubmed | 2.09e-12 | 8 | 16 | 4 | 20610558 | ||
| Pubmed | 1.47e-11 | 12 | 16 | 4 | 18161889 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.47e-11 | 12 | 16 | 4 | 20308471 | |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 4.26e-11 | 57 | 16 | 5 | 21886157 | |
| Pubmed | 7.99e-11 | 3 | 16 | 3 | 12051676 | ||
| Pubmed | 9.06e-11 | 66 | 16 | 5 | 19898482 | ||
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 9535849 | ||
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 1898728 | ||
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 8276413 | ||
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 1634050 | ||
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 3.19e-10 | 4 | 16 | 3 | 18223459 | |
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 8280139 | ||
| Pubmed | 3.19e-10 | 4 | 16 | 3 | 15855726 | ||
| Pubmed | 7.98e-10 | 5 | 16 | 3 | 7677729 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 2.79e-09 | 7 | 16 | 3 | 8467709 | |
| Pubmed | 2.79e-09 | 7 | 16 | 3 | 8464825 | ||
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 4.47e-09 | 8 | 16 | 3 | 12695355 | |
| Pubmed | 1.92e-08 | 190 | 16 | 5 | 24816252 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 3.24e-08 | 211 | 16 | 5 | 24097068 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 20686835 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 12480553 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 24641623 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 19406951 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 3141926 | ||
| Pubmed | The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver. | 1.98e-07 | 2 | 16 | 2 | 21266593 | |
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 8068691 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 22450351 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 14570768 | ||
| Pubmed | 1.98e-07 | 2 | 16 | 2 | 26039129 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 15247627 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 19712005 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 11179460 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 19303655 | ||
| Pubmed | Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. | 5.95e-07 | 3 | 16 | 2 | 16969497 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 12732365 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 23611809 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 21383159 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 20860988 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 12644700 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 24255116 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 1.19e-06 | 4 | 16 | 2 | 2108603 | |
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 9271343 | ||
| Pubmed | Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4. | 1.19e-06 | 4 | 16 | 2 | 15486048 | |
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 15057901 | ||
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 26010150 | ||
| Pubmed | Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis. | 4.16e-06 | 7 | 16 | 2 | 19891553 | |
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 10748067 | ||
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 18052087 | ||
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 18719240 | ||
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 20142249 | ||
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 15319294 | ||
| Pubmed | 1.09e-05 | 11 | 16 | 2 | 18695635 | ||
| Pubmed | 2.69e-05 | 17 | 16 | 2 | 19424794 | ||
| Pubmed | 3.02e-05 | 18 | 16 | 2 | 20056724 | ||
| Pubmed | 8.93e-05 | 193 | 16 | 3 | 22589738 | ||
| Pubmed | 1.17e-04 | 35 | 16 | 2 | 18992148 | ||
| Pubmed | 3.46e-04 | 60 | 16 | 2 | 31220272 | ||
| Pubmed | Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. | 4.18e-04 | 66 | 16 | 2 | 20679960 | |
| Interaction | UGT1A3 interactions | 5.16e-06 | 5 | 15 | 2 | int:UGT1A3 | |
| Interaction | UGT1A5 interactions | 4.68e-05 | 14 | 15 | 2 | int:UGT1A5 | |
| Interaction | CYP3A4 interactions | 6.99e-05 | 17 | 15 | 2 | int:CYP3A4 | |
| Interaction | ABT1 interactions | 2.17e-04 | 423 | 15 | 4 | int:ABT1 | |
| Interaction | ZNF467 interactions | 2.90e-04 | 179 | 15 | 3 | int:ZNF467 | |
| Interaction | PURG interactions | 5.51e-04 | 223 | 15 | 3 | int:PURG | |
| Cytoband | 2q37 | 4.35e-13 | 31 | 16 | 5 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 1.16e-08 | 226 | 16 | 5 | chr2q37 | |
| Cytoband | 19p12 | 4.48e-04 | 90 | 16 | 2 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 8.20e-04 | 122 | 16 | 2 | chr19p12 | |
| GeneFamily | UDP glucuronosyltransferases | 5.74e-12 | 32 | 11 | 5 | 363 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.10e-03 | 718 | 11 | 3 | 28 | |
| Coexpression | NFE2L2.V2 | 1.39e-07 | 469 | 15 | 6 | M2870 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP | 3.65e-05 | 16 | 15 | 2 | MM1089 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.23e-05 | 177 | 16 | 3 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.23e-05 | 177 | 16 | 3 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 3.80e-05 | 187 | 16 | 3 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| Drug | AC1MRQNQ | 7.41e-15 | 9 | 15 | 5 | CID003522271 | |
| Drug | Chebi:32663 | 7.41e-15 | 9 | 15 | 5 | CID005460873 | |
| Drug | 3-iodophenol | 7.41e-15 | 9 | 15 | 5 | CID000012272 | |
| Drug | AC1L4J7U | 7.41e-15 | 9 | 15 | 5 | CID000186631 | |
| Drug | DHPASiU | 7.41e-15 | 9 | 15 | 5 | CID000197602 | |
| Drug | 4-nitrophenyl)imidazole | 2.72e-14 | 11 | 15 | 5 | CID000123155 | |
| Drug | AC1O5XMV | 2.72e-14 | 11 | 15 | 5 | CID006442661 | |
| Drug | AC1Q6OQG | 2.84e-14 | 33 | 15 | 6 | CID000009686 | |
| Drug | N-OH-DABZ | 4.65e-14 | 12 | 15 | 5 | CID000051366 | |
| Drug | 7,7,7-triphenylheptanoic acid | 4.65e-14 | 12 | 15 | 5 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 4.65e-14 | 12 | 15 | 5 | CID000160090 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 4.65e-14 | 12 | 15 | 5 | CID000088735 | |
| Drug | 2,4,6-TCB | 4.65e-14 | 12 | 15 | 5 | CID000037247 | |
| Drug | tritanol | 7.56e-14 | 13 | 15 | 5 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 7.56e-14 | 13 | 15 | 5 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 7.56e-14 | 13 | 15 | 5 | CID000000411 | |
| Drug | propranolol glucuronide | 1.18e-13 | 14 | 15 | 5 | CID000119515 | |
| Drug | PCB-61 | 1.18e-13 | 14 | 15 | 5 | CID000036401 | |
| Drug | sulforaphane nitrile | 1.76e-13 | 15 | 15 | 5 | CID000543743 | |
| Drug | afloqualone | 1.76e-13 | 15 | 15 | 5 | CID000002040 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.76e-13 | 15 | 15 | 5 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 1.76e-13 | 15 | 15 | 5 | CID000010752 | |
| Drug | naphthyl sulphate | 1.76e-13 | 15 | 15 | 5 | CID000114775 | |
| Drug | 1'-hydroxyestragole | 2.56e-13 | 16 | 15 | 5 | CID000040003 | |
| Drug | bilirubin-phosphate | 2.56e-13 | 16 | 15 | 5 | CID005497144 | |
| Drug | quercetin-3,4'-diglucoside | 2.56e-13 | 16 | 15 | 5 | CID005320835 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 3.63e-13 | 17 | 15 | 5 | CID000003573 | |
| Drug | 6-hydroxychrysene | 3.63e-13 | 17 | 15 | 5 | CID000037766 | |
| Drug | ApApG | 5.02e-13 | 18 | 15 | 5 | CID003081975 | |
| Drug | C1 11-32 | 5.02e-13 | 18 | 15 | 5 | CID000443077 | |
| Drug | C11131 | 5.02e-13 | 18 | 15 | 5 | CID000443076 | |
| Drug | SureCN12722713 | 5.02e-13 | 18 | 15 | 5 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 5.02e-13 | 18 | 15 | 5 | CID000036614 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 5.02e-13 | 18 | 15 | 5 | CID000152226 | |
| Drug | Br 2 | 5.02e-13 | 18 | 15 | 5 | CID003060900 | |
| Drug | almokalant | 6.82e-13 | 19 | 15 | 5 | CID003033962 | |
| Drug | 9-OH-risperidone | 6.82e-13 | 19 | 15 | 5 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 6.82e-13 | 19 | 15 | 5 | CID000091433 | |
| Drug | AC1Q6OQF | 7.38e-13 | 55 | 15 | 6 | CID000009685 | |
| Drug | AC1L1OBF | 9.09e-13 | 20 | 15 | 5 | CID000032736 | |
| Drug | tectochrysin | 9.09e-13 | 20 | 15 | 5 | CID005281954 | |
| Drug | 4'-hydroxydiclofenac | 9.09e-13 | 20 | 15 | 5 | CID000116545 | |
| Drug | estriol-16-glucuronide | 1.19e-12 | 21 | 15 | 5 | CID000122281 | |
| Drug | Benzamidoxime hydrochloride | 1.19e-12 | 21 | 15 | 5 | CID000069186 | |
| Drug | dulcin | 1.19e-12 | 21 | 15 | 5 | CID000009013 | |
| Drug | amonafide | 1.54e-12 | 22 | 15 | 5 | CID000050515 | |
| Drug | N-methylpiperazine | 1.54e-12 | 22 | 15 | 5 | CID000053167 | |
| Drug | 2-hydroxyestradiol | 1.73e-12 | 63 | 15 | 6 | CID000009684 | |
| Drug | estradiol-3-glucuronide | 1.97e-12 | 23 | 15 | 5 | CID000066651 | |
| Drug | phenanthridine | 1.97e-12 | 23 | 15 | 5 | CID000009189 | |
| Drug | amidoxime | 1.97e-12 | 23 | 15 | 5 | CID000465967 | |
| Drug | AS-3201 | 2.49e-12 | 24 | 15 | 5 | CID000153948 | |
| Drug | N-acetylbenzidine | 3.11e-12 | 25 | 15 | 5 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 3.11e-12 | 25 | 15 | 5 | CID000006796 | |
| Drug | 5-MOP | 3.11e-12 | 25 | 15 | 5 | CID000002355 | |
| Drug | N-phenylmaleimide | 3.11e-12 | 25 | 15 | 5 | CID000013662 | |
| Drug | AzMC | 3.11e-12 | 25 | 15 | 5 | CID000064986 | |
| Drug | DiMeIQx | 4.72e-12 | 27 | 15 | 5 | CID000104739 | |
| Drug | diflunisal | 4.72e-12 | 27 | 15 | 5 | CID000003059 | |
| Drug | H-Ni | 5.74e-12 | 28 | 15 | 5 | CID000445665 | |
| Drug | CARMINE | 5.74e-12 | 28 | 15 | 5 | CID000014749 | |
| Drug | N-hydroxy-4-aminobiphenyl | 5.74e-12 | 28 | 15 | 5 | CID000081261 | |
| Drug | erucin | 5.74e-12 | 28 | 15 | 5 | CID000078160 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 6.94e-12 | 29 | 15 | 5 | CID005375667 | |
| Drug | AC1L1JAL | 6.94e-12 | 29 | 15 | 5 | CID000004954 | |
| Drug | 7-hydroxycoumarin glucuronide | 6.94e-12 | 29 | 15 | 5 | CID000125641 | |
| Drug | iberin | 6.94e-12 | 29 | 15 | 5 | CID000010455 | |
| Drug | trans-3'-hydroxycotinine | 6.94e-12 | 29 | 15 | 5 | CID000000414 | |
| Drug | paricalcitol | 8.32e-12 | 30 | 15 | 5 | CID005281104 | |
| Drug | AC1L9E0Q | 8.32e-12 | 30 | 15 | 5 | CID000443095 | |
| Drug | dihydroartemisinin | 8.32e-12 | 30 | 15 | 5 | CID000107770 | |
| Drug | tolcapone | 8.32e-12 | 30 | 15 | 5 | CID004659569 | |
| Drug | 4-ethylphenol | 9.92e-12 | 31 | 15 | 5 | CID000031242 | |
| Drug | PCB 156 | 9.92e-12 | 31 | 15 | 5 | CID000038019 | |
| Drug | 4'-HPPH | 9.92e-12 | 31 | 15 | 5 | CID000017732 | |
| Drug | Muracein C | 1.17e-11 | 32 | 15 | 5 | CID003086323 | |
| Drug | NNAL | 1.17e-11 | 32 | 15 | 5 | CID000104856 | |
| Drug | indole-2-carboxylic acid | 1.17e-11 | 32 | 15 | 5 | CID000072899 | |
| Drug | 6-methylsalicylic acid | 1.38e-11 | 33 | 15 | 5 | CID000011279 | |
| Drug | norbuprenorphine | 1.38e-11 | 33 | 15 | 5 | CID000114976 | |
| Drug | geniposide | 1.38e-11 | 33 | 15 | 5 | CID000107848 | |
| Drug | BP-3,6-quinol | 1.38e-11 | 33 | 15 | 5 | CID000119292 | |
| Drug | R(-)-Denopamine | 1.38e-11 | 33 | 15 | 5 | CID000003818 | |
| Drug | estragole | 1.62e-11 | 34 | 15 | 5 | CID000008815 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 1.89e-11 | 35 | 15 | 5 | CID010436171 | |
| Drug | AC1NOWCJ | 1.89e-11 | 35 | 15 | 5 | CID005120112 | |
| Drug | estrone-3-glucuronide | 1.89e-11 | 35 | 15 | 5 | CID000115255 | |
| Drug | glucoraphanin | 2.20e-11 | 36 | 15 | 5 | CID000656556 | |
| Drug | AC1L9DGV | 2.20e-11 | 36 | 15 | 5 | CID000417381 | |
| Drug | anisole | 2.20e-11 | 36 | 15 | 5 | CID000007519 | |
| Drug | bevirimat | 2.20e-11 | 36 | 15 | 5 | CID000457928 | |
| Drug | muraglitazar | 2.20e-11 | 36 | 15 | 5 | CID000206044 | |
| Drug | 6beta-hydroxytestosterone | 2.54e-11 | 37 | 15 | 5 | CID000065543 | |
| Drug | N-Fg | 2.54e-11 | 37 | 15 | 5 | CID000445227 | |
| Drug | l-borneol | 2.54e-11 | 37 | 15 | 5 | CID000010049 | |
| Drug | acotiamide | 2.54e-11 | 37 | 15 | 5 | CID005282338 | |
| Drug | 4-methylumbelliferyl glucuronide | 2.92e-11 | 38 | 15 | 5 | CID000091553 | |
| Drug | x Me | 2.92e-11 | 38 | 15 | 5 | CID009600424 | |
| Drug | acacetin | 2.92e-11 | 38 | 15 | 5 | CID005280442 | |
| Drug | 1-phenylimidazole | 3.35e-11 | 39 | 15 | 5 | CID000081595 | |
| Disease | X-11442 measurement | 1.35e-15 | 9 | 14 | 5 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.35e-15 | 9 | 14 | 5 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.35e-15 | 9 | 14 | 5 | EFO_0004739 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.35e-15 | 9 | 14 | 5 | EFO_0004570, GO_0009410 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 2.70e-15 | 10 | 14 | 5 | EFO_0802185 | |
| Disease | bilirubin measurement, response to tenofovir | 2.70e-15 | 10 | 14 | 5 | EFO_0004570, EFO_0009279 | |
| Disease | insomnia, bilirubin measurement | 4.96e-15 | 11 | 14 | 5 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 4.96e-15 | 11 | 14 | 5 | EFO_0800972 | |
| Disease | aldosterone measurement | 4.96e-15 | 11 | 14 | 5 | EFO_0010219 | |
| Disease | X-21796 measurement | 4.96e-15 | 11 | 14 | 5 | EFO_0800825 | |
| Disease | biliverdin measurement | 8.49e-15 | 12 | 14 | 5 | EFO_0021033 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 6.63e-14 | 17 | 14 | 5 | EFO_0004611, EFO_0007800 | |
| Disease | xanthurenate measurement | 1.27e-12 | 29 | 14 | 5 | EFO_0010551 | |
| Disease | response to dolutegravir | 1.52e-12 | 30 | 14 | 5 | EFO_0600017 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.22e-12 | 8 | 14 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.22e-12 | 8 | 14 | 4 | EFO_0022118 | |
| Disease | X-24849 measurement | 2.22e-12 | 8 | 14 | 4 | EFO_0800909 | |
| Disease | cholelithiasis, bilirubin measurement | 2.22e-12 | 8 | 14 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11530 measurement | 2.22e-12 | 8 | 14 | 4 | EFO_0021249 | |
| Disease | X-11522 measurement | 2.22e-12 | 8 | 14 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.22e-12 | 8 | 14 | 4 | EFO_0800692 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.22e-12 | 8 | 14 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.22e-12 | 8 | 14 | 4 | EFO_0800766 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.22e-12 | 8 | 14 | 4 | EFO_0801034 | |
| Disease | X-11880 measurement | 3.99e-12 | 9 | 14 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.99e-12 | 9 | 14 | 4 | EFO_0020691 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.99e-12 | 9 | 14 | 4 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.99e-12 | 9 | 14 | 4 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.99e-12 | 9 | 14 | 4 | EFO_0801036 | |
| Disease | X-21448 measurement | 6.65e-12 | 10 | 14 | 4 | EFO_0800816 | |
| Disease | X-23974 measurement | 6.65e-12 | 10 | 14 | 4 | EFO_0800867 | |
| Disease | p-cresol glucuronide measurement | 1.57e-11 | 12 | 14 | 4 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 2.26e-11 | 13 | 14 | 4 | EFO_0802007 | |
| Disease | urate measurement, spine bone mineral density | 4.86e-11 | 58 | 14 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | angiopoietin-related protein 1 measurement | 9.66e-11 | 18 | 14 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 1.89e-10 | 21 | 14 | 4 | EFO_0010623 | |
| Disease | cholelithiasis | 4.12e-10 | 88 | 14 | 5 | EFO_0004799 | |
| Disease | gallstones | 1.17e-09 | 108 | 14 | 5 | EFO_0004210 | |
| Disease | pregnenetriol sulfate measurement | 1.40e-08 | 11 | 14 | 3 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.40e-08 | 11 | 14 | 3 | EFO_0600039 | |
| Disease | pregnenetriol disulfate measurement | 2.42e-08 | 13 | 14 | 3 | EFO_0800587 | |
| Disease | thyroxine measurement | 5.70e-08 | 83 | 14 | 4 | EFO_0005130 | |
| Disease | X-21441 measurement | 5.76e-08 | 17 | 14 | 3 | EFO_0800814 | |
| Disease | hormone measurement | 5.98e-08 | 84 | 14 | 4 | EFO_0004730 | |
| Disease | bilirubin measurement | 1.32e-06 | 442 | 14 | 5 | EFO_0004570 | |
| Disease | metabolite measurement | 4.20e-06 | 560 | 14 | 5 | EFO_0004725 | |
| Disease | serum N-desmethylclozapine measurement | 5.84e-06 | 8 | 14 | 2 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 5.84e-06 | 8 | 14 | 2 | EFO_0600038 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.36e-05 | 713 | 14 | 5 | EFO_0005689 | |
| Disease | serum metabolite measurement | 5.24e-05 | 945 | 14 | 5 | EFO_0005653 | |
| Disease | hepatitis B (is_implicated_in) | 1.38e-04 | 37 | 14 | 2 | DOID:2043 (is_implicated_in) | |
| Disease | vitamin D deficiency | 1.38e-04 | 37 | 14 | 2 | EFO_0003762 | |
| Disease | apolipoprotein B measurement | 2.11e-04 | 663 | 14 | 4 | EFO_0004615 | |
| Disease | vitamin D measurement, COVID-19 | 2.43e-04 | 49 | 14 | 2 | EFO_0004631, MONDO_0100096 | |
| Disease | vitamin D measurement | 4.85e-04 | 336 | 14 | 3 | EFO_0004631 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKCLGKKGRVKKAHK | 516 | P35503 | |
| LCGKKFKRKKDVKRH | 381 | Q9H116 | |
| GARKSKKLGKLKGIH | 671 | P08235 | |
| SAGCRKGKHKRKKLP | 731 | P56645 | |
| GVCRKTKKKHLKKSK | 376 | Q86Y01 | |
| KSKKKKGHKGKNCII | 816 | Q96MT3 | |
| RRIVKCGKLHKKGRK | 196 | Q96PZ2 | |
| HHFKRKRGKKKGKIL | 91 | Q8NAN2 | |
| VKHKKKGKKQKHCRR | 436 | P30414 | |
| KGKKQKHCRRHKQTK | 441 | P30414 | |
| KIRHTRKKPFKCKKC | 196 | Q8IYN0 | |
| KCLGKKGRVKKAHKS | 516 | P22309 | |
| RKCLGKKGRVKKAHK | 516 | P35504 | |
| KHCKLKKKSKEEGAR | 161 | A0A1B0GTY4 | |
| KIRHTGKKPFKCKKC | 196 | Q9H8G1 | |
| CLGKKGRVKKAHKSK | 516 | P19224 | |
| RKCLGKKGRVKKAHK | 516 | P22310 |